Yuhan Corporation

KRX:000100.KS

126,700 (KRW) • At close September 6, 2024
Bedrijfsnaam Yuhan Corporation
Symbool 000100.KS
Munteenheid KRW
Prijs 125,600
Beurswaarde 9,268,522,757,600
Dividendpercentage 0.64%
52-weken bereik 52,285.7 - 149,800
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Wook-Je Cho
Website https://www.yuhan.co.kr

An error occurred while fetching data.

Over Yuhan Corporation

Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally. It offers antivirals, antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds; Revanex, an acid pump antagonist for the treatment of peptic ulcers and gastritis-related mucosal

Vergelijkbare Aandelen

SK Biopharmaceuticals Co., Ltd. logo

SK Biopharmaceuticals Co., Ltd.

326030.KS

104,100 KRW

SK bioscience Co.,Ltd. logo

SK bioscience Co.,Ltd.

302440.KS

51,800 KRW

SD BioSensor, Inc logo

SD BioSensor, Inc

137310.KS

9,430 KRW

Hanmi Pharm. Co., Ltd. logo

Hanmi Pharm. Co., Ltd.

128940.KS

315,500 KRW

Hanmi Science Co., Ltd. logo

Hanmi Science Co., Ltd.

008930.KS

32,650 KRW

Green Cross Corporation logo

Green Cross Corporation

006280.KS

145,800 KRW

Daewoong pharmaceutical Co.,Ltd logo

Daewoong pharmaceutical Co.,Ltd

069620.KS

130,100 KRW

Shin Poong Pharm.Co.,Ltd. logo

Shin Poong Pharm.Co.,Ltd.

019170.KS

12,130 KRW

Daewoong Co., Ltd. logo

Daewoong Co., Ltd.

003090.KS

23,550 KRW

Chong Kun Dang Pharmaceutical Corp. logo

Chong Kun Dang Pharmaceutical Corp.

185750.KS

110,600 KRW

Financiële Gegevens

Cijfers zijn in miljoenen (KRW)

Cijfers zijn in miljoenen (KRW)